Thumb Osteoarthritis Prognosis for Supported Self-managment (TOPS)

Outcome and Prognosis of Supported Self-management in Thumb Base Osteoarthritis: A Prospective Cohort Study

Background Thumb base osteoarthritis (OA) is common in adults 40 years and over. It affects a person's ability to work, be independent and care for others. Sufferers complain of severe pain and difficulty in completing everyday tasks. The main treatment for the condition is advice on how a person can manage their condition (self-management), reduce their pain, strengthen their hands with exercises and practical tips on tackling painful tasks, sometimes providing a hand splint for support. The treatment is provided by occupational and physiotherapists. We know that this treatment helps suffers in the short term (up to three months). But the research was done in people with few other health problems and while self-management support helps provide pain relief for most people, there are some people who don't benefit. The aim of this research is to see how pain and other hand problems change over a period of six months after the start of treatment, to understand people's experience of care, and examine why some people improve, and some do not.

Research Plan In patients receiving treatment for thumb base OA at four NHS sites, who are willing to take part, this research will: -

  1. Record changes in symptoms and quality of life at three and six months from when treatment began in a postal questionnaire/survey.
  2. Discuss the experience of care and people's beliefs about what makes treatment a success by interviewing a small group of patients.
  3. Analyse patient characteristics, to see if it is possible to determine how they will respond to treatment.
  4. Develop recommendations for improving care.

Study Overview

Detailed Description

Background

Thumb base osteoarthritis occurs in 21-45% of the adult population over 40 and can cause severe pain and difficulty with essential everyday hand use. Guidelines recommend that those seeking care should receive education and exercises (supported self-management), and, if needed, splints. However, these guidelines are based on research reporting outcomes at three months or less, often excluding those with other hand conditions and co-morbidities. In these studies, self-management was found to provide pain relief for about half of study participants, with the remaining individuals not benefiting significantly in terms of pain at three months. Furthermore, there is no research on the patient's experience of care.

The aim of this study is to investigate, using a mixed methods approach the outcomes, prognosis, and experiences of care in patients receiving usual National Health Service (NHS) care which consists of a supported self-management programme, and to generate recommendations for optimising care for thumb base Osteoarthritis (OA). The design will be a prospective longitudinal cohort study linked with a qualitative interview and focus group study. Four NHS sites will recruit 150 people with symptomatic thumb base OA. The primary outcome is the AUSCAN hand pain scale, additionally baseline assessments will be carried out for measures of hand function, quality of life and known musculoskeletal prognostic factors. The study endpoint is six months. Outcome assessments will be conducted by postal/online questionnaire (as applicable) at three and six months. The qualitative and quantitative results from this study will be integrated and presented to a stakeholder group meeting, where participants will be guided to generate recommendations for future care.

Objectives

  1. To determine the 6-month outcomes (change in pain, hand function, participation in social roles and activities, and quality of life) in a cohort of patients with thumb base OA receiving supported self-management in specialist NHS services. And to estimate the proportion of those who respond after treatment.
  2. To evaluate patient experiences with care and determine what factors patients and clinicians perceive contribute to outcome (candidate prognostic factors).
  3. To investigate the association of prognostic factors with pain and function outcomes.
  4. To integrate qualitative and quantitative findings to generate recommendations for optimising current care.

STUDY DESIGN

This study is a mixed methods convergent parallel design, and is divided into three parts:

  1. Prospective cohort study in people with symptomatic thumb base OA receiving a supported self-management programme to provide 3- and 6-month outcome data; and record any subsequent stepped care provided according to existing guidelines.
  2. Qualitative Research: semi-structured interviews will describe the experience of care and explore patient perception of factors related to outcome, and a focus group will explore treating therapist perceptions of factors related to outcome.
  3. Stakeholder and PPIE meeting to discuss and disseminate the results with patients and clinicians and to generate recommendations for improving care for patients.

Study Type

Observational

Enrollment (Estimated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

This study will recruit participants seeking care for a painful thumb, with a clinical diagnosis (signs and symptoms) of thumb base OA. Radiographs are not required to diagnose and provide therapy treatment for thumb base OA, clinical assessment alone will be used (NICE guidelines).

Description

Inclusion Criteria:

  • Symptomatic thumb base OA, confirmed with at least one of the following clinical signs:

    • Hard tissue enlargement of the thumb carpometacarpal joint
    • Squaring at the base of the thumb
    • Crepitus on movement of the thumb carpometacarpal joint
    • Positive adduction provocation test
    • Positive extension provocation test
    • Positive pressure shear test
    • Pain on palpation of the dorso-radial aspect of the thumb carpometacarpal joint
  • Able to give written informed consent.
  • Available to attend Occupational Therapy/Physiotherapy/Hand Therapy sessions.

Exclusion Criteria:

  • Currently receiving therapy care for thumb base OA.
  • Fractures or significant injury or surgery to the wrist or hand on the included side in the previous 6 months.
  • Previous surgery to the basal thumb joint on the included side.
  • Red flags i.e., diagnosed rheumatic condition (gout, rheumatoid arthritis), progressive neurological signs, any acutely swollen hand joint, serious illness, or disease.
  • Participants of any drug or medical device trial in the last 12 weeks.
  • Recent steroid injection in their included basal thumb joint (2 months prior to baseline appointment).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Australian Canadian Osteoarthritis Hand Index (AUSCAN) Hand Pain Subscale
Time Frame: 6 months
The AUSCAN is a patient-rated, disease-specific, and hand-specific questionnaire with a pain subscale comprising of five items measuring hand pain (0-20), greater scores indicate worse pain.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thumb Pain Frequency
Time Frame: 3 & 6 months
5 point Likert scale (never- always)
3 & 6 months
PSEQ
Time Frame: 3 & 6 months
Pain self efficacy questionnaire
3 & 6 months
EQ-5D-5L
Time Frame: 3 & 6 months
Generic health status and quality of life
3 & 6 months
PROMIS SF
Time Frame: 3 & 6 months
Social participation and difficulty in daily life
3 & 6 months
Australian Canadian Osteoarthritis Hand Index (AUSCAN) Hand Pain & Function Subscales
Time Frame: 3 & 6 months
The AUSCAN is a patient-rated, disease-specific, and hand-specific questionnaire comprising of five items measuring hand pain (0-20), one item measuring stiffness (0-4), and nine measuring hand function (0-36). The total score ranges from 0-60 with higher scores indicating more pain, stiffness, or functional limitation.
3 & 6 months
Numerical rating scale (NRS) Thumb pain (0-10)
Time Frame: 3 & 6 months
NRS specific to thumb pain severity over the last week, higher scores indicate greater pain severity.
3 & 6 months
Osteoarthritis Research Society International (OARSI) responder Criteria
Time Frame: 3 & 6 months
Participants are evaluated as a responder or non-responder to treatment. This is calculated based on a global rating of change (GROC) question with 6 items (on a Likert scale ranging from completely recovered to much worse); and absolute or relative changes in AUSCAN scores for pain and function (Ref Pham 2004).
3 & 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prognostic factor analysis
Time Frame: 6 months
Candidate prognostic factors for response to conservative management will be collected at baseline only. These factors have been identified from a systematic review of the prognosis for pain and function in hand and thumb base OA (61). The prognostic factors fall into the following categories clinical signs, general health, psychological factors, and perceived symptom severity.
6 months
Qualitative data
Time Frame: 3-6 months
Topic guides have been created to explore the expereince of receiving care and on participant and therapist perceived prognostic factors.
3-6 months
The Osteoarthritis Quality Indicator (OA-QI)
Time Frame: 3 & 6 months
The OA-QI questionnaire will be used to assess patient-perceived quality of care.
3 & 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 8, 2023

Primary Completion (Estimated)

March 1, 2025

Study Completion (Estimated)

August 1, 2025

Study Registration Dates

First Submitted

June 27, 2023

First Submitted That Met QC Criteria

June 27, 2023

First Posted (Actual)

July 6, 2023

Study Record Updates

Last Update Posted (Actual)

December 21, 2023

Last Update Submitted That Met QC Criteria

December 18, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

The data is not being uploaded to an external repository. Keele University have a process for data sharing, and all requests would follow their usual process. The CTU can be contacted from the website https://www.keele.ac.uk/ctu/

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis Thumb

Clinical Trials on This study will observe participants who receive a supported self management approach for thumb base osteoarthritis but it is not an interventional study.

3
Subscribe